Anti-IGF1R [IGFR 17-69]

Catalogue Number: AB01285-23.0-BT-ABA

Manufacturer:Vector Laboratories, Inc (ABA)
Type:Monoclonal Secondary Antibody - Unconjugated
Alias:CD221; IGF1 receptor; Insulin-like growth factor 1 receptor; type I IGF receptor; Insulin-like growth factor I receptor; IGF-I receptor; 17 69
Shipping Condition:Blue Ice
Unit(s): 1 mg
Host name: Rabbit
Clone: IGFR 17-69
Isotype: IgG
Immunogen: This antibody was raised by immunising BALB/c mice with transfected mouse fibroblasts expressing high levels of human IGF1R (IGF1R/3T3).
Application: IP, Blk

Additional Text

Gene Name

IGF1R

Gene ID

3480

Uniprot ID

P08069

Purification

Purified

Antibody Clonality

Recombinant Monoclonal

Storage Note

Store at 4⁰C for up to 3 months. Note, this antibody is provided without added preservatives, it is therefore recommed this antibody be handled under sterile conditions. For longer storage, aliquot and store at -20⁰C.

Application Notes

The ability of this antibody to bind human IGF1R has been confirmed in IGF1 binding assays using both IG1FR-overexpressing IGF1R/3T3 cells and soluble receptors (Soos et al, 1992). This antibody efficiently precipitates human IGF1R (Soos et al, 1992), and has been used in immunoprecipitation analysis of 293 cells transfected with hIGF1R or chimeric hIGF1R-insulin receptor constructs (Schumacher et al, 1993) and solubilized microsomal membrane samples prepared from a range of human tissues (Bailyes et al, 1997). Given its reactivity with rabbit IGF1R, this antibody has also been used in immunoprecipitation analysis of rabbit tissue samples (Bailyes et al, 1997). When immobilised, this antibody has been shown to remove essentially all soluble, IGF1R/3T3-derived IGF1R (Soos et al, 1992) and human placental membrane-derived IGF1R in immunodepletion experiments (Soos et al, 1993). This antibody weakly inhibits IGF1 binding to its receptor (Soos et al, 1993).

Short Description

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.